These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2953663)

  • 1. Effects of cyproterone acetate (CPA) on serum lipoproteins when administered alone and in combination with ethinyl estradiol (EE).
    Lindberg UB; Crona N; Enk L; Samsioe G; Silfverstolpe G
    Horm Metab Res; 1987 May; 19(5):222-5. PubMed ID: 2953663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose and duration effects of estradiol valerate on serum and lipoprotein lipids.
    Enk L; Crona N; Samsioe G; Silfverstolpe G
    Horm Metab Res; 1986 Aug; 18(8):551-4. PubMed ID: 3530933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effect at six and twelve months of cyproterone acetate (2 mg) combined with ethinyl estradiol (35 micrograms) in 31 patients.
    Vexiau P; Vexiau-Robert D; Martineau I; Hardy N; Villette JM; Fiet J; Cathelineau G
    Horm Metab Res; 1990 Apr; 22(4):241-5. PubMed ID: 2141001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
    Larsson-Cohn U; Wallentin L; Zador G
    Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
    Crona N; Silfverstolpe G; Samsioe G
    Eur J Obstet Gynecol Reprod Biol; 1985 Jun; 19(6):365-74. PubMed ID: 3160616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception.
    Rådberg T; Gustafson A; Skryten A; Karlsson K
    Horm Metab Res; 1982 Feb; 14(2):61-5. PubMed ID: 7040192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical effects of the anti-androgen cyproterone acetate on lipid and lipoprotein metabolism.
    Wynn V; Godsland IF; Seed M; Jacobs HS
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):183-91. PubMed ID: 2940034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drug.
    Larsson-Cohn U; Fåhraeus L; von Schenck H; Wallentin L
    Acta Obstet Gynecol Scand; 1986; 65(2):125-8. PubMed ID: 2941968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids and lipoproteins in acute renal failure.
    Mydlík M; Ahlers I; Derzsiová K; Takác M
    Proc Eur Dial Transplant Assoc; 1976; 12():389-96. PubMed ID: 180523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol ester metabolism in plasma during estrogen and antiandrogen treatment in men with carcinoma of the prostate.
    Wallentin L; Varenhorst E
    J Lab Clin Med; 1981 Dec; 98(6):906-16. PubMed ID: 6458644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
    Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
    Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.